Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03331367 · ClinicalTrials.gov registry record · NA
Investigating and Characterizing the Immune Response to Prostate Cancer
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03331367 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 40 participants.
The verdict
NCT03331367, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is a clinical study to investigate and characterize the immune response profile to four different prostate cancer treatments (total cryotherapy, focal cryotherapy, Cyberknife SBRT, and radical prostatectomy) in patients with localized prostate cancer.
Interventions
- PROCEDURE Blood draw
- PROCEDURE Urine sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2020-02-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03331367
The ClinicalTrials.gov registry entry for NCT03331367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT03331367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03331367 about?
NCT03331367 is a clinical study titled "Investigating and Characterizing the Immune Response to Prostate Cancer". This study is a clinical study to investigate and characterize the immune response profile to four different prostate cancer treatments (total cryotherapy, focal cryotherapy, Cyberknife SBRT, and radical prostatectomy) in patients with localized prostate cancer.
What is the current status of trial NCT03331367?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-09-14. Estimated completion is 2020-02-25.
What interventions are being tested in trial NCT03331367?
The interventions under investigation include: Blood draw (PROCEDURE), Urine sample (PROCEDURE).
Who is sponsoring clinical trial NCT03331367?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.